Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal oxytocin for chronic neck and shoulder musculoskeletal pain
ACTRN12616000532404Phase 2Completed
- Sponsor
- Dr Melita Giummarra
- Start
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxytocin in cervicalgia and shoulder pain (2 arms), sponsored by Dr Melita Giummarra. Primary endpoints: Maximum change in heart rate during pain anxiety paradigm, Maximum change in skin conductance during pain anxiety paradigm and 1 more. Started Sep 2015; status: completed.
02
Drugs
oxytocin
03
Conditions
cervicalgiashoulder pain
Beyond the preview
Go deeper on ACTRN12616000532404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000532404.